Article Details

Benefits of Disease-Modifying Therapy in MS Patients - Physician's Weekly

Retrieved on: 2022-03-21 10:35:32

Tags for this article:

Click the tags to see associated articles and topics

Benefits of Disease-Modifying Therapy in MS Patients - Physician's Weekly. View article details on hiswai:

Excerpt

... sought to forecast the conditional average treatment effect (CATE) for people on anti-CD20 monoclonal antibodies and laquinimod for a study.

Article found on: www.physiciansweekly.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up